Here, we characterized gene expression (mRNA and protein levels) of MTAP and CDKN2A in seven breast cancer cell lines and performed a promoter methylation analysis of MTAP (Fig 3, Table 2 and S1 Fig). This evidence concerns the gene CDKN2A and breast carcinoma.